Dynavax Technologies has revealed promising topline outcomes from the initial part of its Phase I/II clinical trial, ...

Results from the first part of a Phase I/II trial (NCT06569823) showed that Z-1018 generated immune responses comparable to ...

Dynavax Technologies said on Thursday its experimental shingles vaccine generated a similar immune response as GSK's ...

The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...

Dynavax Technologies Corporation (NASDAQ:DVAX) surged 8% Thursday following the announcement of encouraging topline data from ...

A study published this week in the peer-reviewed journal Scientific Reports examined the long-term impacts of having shingles ...

One of the goals of the Insurance Institute for Business and Home Safety is to make homes and commercial buildings stronger.

The rash typically develops on one side of the body or face and forms blisters that scab over in 7–10 days, usually healing within two to four weeks. While shingles is more common in older adults, it ...

Ulka Sasaki is going to miss Pro Wrestling NOAH dates on August 24th and 25th due to shingles. More information in the ...

Although shingles vaccination rates have inched upward in recent years, only a third of adults who were 60 or older in 2016 had received the Zostavax vaccine, the CDC says.

Shingles will strike 1 in 3 Americans during their lifetimes — most between ages 60 and 70. Folks in their 60s get shingles at roughly twice the rate as folks in their 50s, reports the CDC.